Results 231 to 240 of about 37,814 (299)

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

open access: yesOphthalmology (Rochester, Minn.), 2012
Daniel F. Martin   +8 more
semanticscholar   +1 more source

Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes. [PDF]

open access: yesBMC Ophthalmol
Comcali S   +10 more
europepmc   +1 more source

Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review. [PDF]

open access: yesOphthalmol Ther
Hariprasad SM   +8 more
europepmc   +1 more source

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.

open access: yesJAMA Ophthalmol
Pieramici DJ   +12 more
europepmc   +1 more source

Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Colombia. [PDF]

open access: yesJ Health Econ Outcomes Res
Samacá-Samacá D   +9 more
europepmc   +1 more source

Acute generalised exanthematous pustulosis following intravitreal Ranibizumab

open access: green, 2011
David C. Bosanquet   +4 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy